Nemaura Medical Inc., a cutting-edge medical technology firm based in New York, is dedicated to creating and marketing state-of-the-art diagnostic medical devices aimed at improving healthcare outcomes. The company's flagship product is the revolutionary sugarBEAT, which enables non-invasive continuous glucose monitoring for people living with Type I and Type II diabetes, as well as screening pre-diabetic patients. In addition, Nemaura Medical Inc. offers proBEAT, a program designed to provide users with wellness guidance notes to prompt and educate them on the various factors that can affect blood sugar levels. The company also conducts diabetes prevention and reversal programs. Founded in 2009, Nemaura Medical Inc. is at the forefront of cutting-edge medical technology, offering innovative solutions to improve healthcare outcomes for patients across the globe.
Nemaura Medical's ticker is NMRD
The company's shares trade on the NASDAQ stock exchange
They are based in New York City, New York
There are 11-50 employees working at Nemaura Medical
It is nemauramedical.com/about-us
Nemaura Medical is in the Healthcare sector
Nemaura Medical is in the Medical Appliances & Equipment industry
The following five companies are Nemaura Medical's industry peers: